Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poussot Tapped As Wyeth CEO – Inherits Full Pipeline, Takeover Concerns

Executive Summary

With the appointment of 20-year veteran Bernard Poussot as CEO, Wyeth is following a traditional approach to chief exec succession -avoiding drama by selecting a well-groomed insider with the standard pedigree from the business and marketing sides of the operation

You may also be interested in...



Wyeth Looks To Specialty Markets As Generics Challenge Current Model

Wyeth's R&D pipeline is evolving the firm toward more specialized areas as several of its blockbuster products face patent expirations and generic challenges

Wyeth Looks To Specialty Markets As Generics Challenge Current Model

Wyeth's R&D pipeline is evolving the firm toward more specialized areas as several of its blockbuster products face patent expirations and generic challenges

Lilly Leadership Falls To Lechleiter In ’08 As Taurel Resigns As CEO

The appointment of Lilly President and Chief Operating Officer John Lechleiter to CEO should be a smooth transition in early 2008 when longtime chief exec Sidney Taurel retires

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel